MARKET

ABBV

ABBV

Abbvie Inc
NYSE
227.50
+6.61
+2.99%
After Hours: 227.50 0 0.00% 19:50 02/12 EST
OPEN
221.57
PREV CLOSE
220.89
HIGH
229.05
LOW
220.91
VOLUME
8.71M
TURNOVER
--
52 WEEK HIGH
241.12
52 WEEK LOW
159.05
MARKET CAP
402.08B
P/E (TTM)
171.66
1D
5D
1M
3M
1Y
5Y
1D
AbbVie files lawsuit over selection of Botox for Medicare price negotiations
Seeking Alpha · 10h ago
AbbVie’s Korean Rinvoq Study Wraps Up, Bolstering Real-World Data for Immunology Growth
TipRanks · 13h ago
54 Stocks, 9 Megatrends: My Favorite Places To Be While Capital Is 'Forced'
Seeking Alpha · 17h ago
1 Reason I'm Never Selling AbbVie Stock
The Motley Fool · 20h ago
AbbVie Sues HHS Over Selection Of Botox For IRA Medicare Drug Negotiations
Benzinga · 1d ago
2 Urgent Sells And 2 No Brainer Dividend Buys
Seeking Alpha · 1d ago
AbbVie Updates Phase 2 Elezanumab Study in Acute Cervical Spinal Cord Injury: What Investors Should Watch
TipRanks · 1d ago
P/E Ratio Insights for AbbVie
Benzinga · 1d ago
More
About ABBV
AbbVie Inc. is a global, diversified research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its investigational candidate, bretisilocin, is for the treatment of patients with moderate-to-severe major depressive disorder (MDD).

Webull offers AbbVie Inc stock information, including NYSE: ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.